CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 471 filers reported holding CRISPR THERAPEUTICS AG in Q3 2021. The put-call ratio across all filers is 1.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,096,127 | -26.8% | 26,965 | +17.6% | 0.18% | -22.0% |
| Q3 2022 | $1,498,000 | -7.8% | 22,920 | -14.3% | 0.23% | +58.7% |
| Q2 2022 | $1,625,000 | +204.9% | 26,738 | +214.6% | 0.14% | +210.9% |
| Q1 2022 | $533,000 | -39.8% | 8,499 | +7.5% | 0.05% | -28.1% |
| Q3 2021 | $885,000 | +9.1% | 7,906 | +49.2% | 0.06% | +16.4% |
| Q4 2020 | $811,000 | +243.6% | 5,300 | +64.9% | 0.06% | +243.8% |
| Q2 2020 | $236,000 | – | 3,215 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $31,294,000 | 31.24% |
| NEA Management Company, LLC | 1,590,002 | $365,593,000 | 10.56% |
| Ariose Capital Management Ltd | 37,900 | $2,379,000 | 9.30% |
| ARK Investment Management | 9,404,071 | $590,294,000 | 2.46% |
| NIA IMPACT ADVISORS, LLC | 80,082 | $5,027,000 | 2.44% |
| Nikko Asset Management Americas, Inc. | 4,619,747 | $291,044,000 | 2.14% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,139,000 | 1.98% |
| Integral Health Asset Management, LLC | 120,000 | $7,532,000 | 1.96% |
| Valiant Capital Management, L.P. | 240,683 | $15,108,000 | 1.73% |
| Deuterium Capital Management, LLC | 18,000 | $1,130,000 | 1.45% |